Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
Journal for ImmunoTherapy of Cancer (2015)
  • Marka Crittenden, Providence Portland Medical Center
  • Keith S Bahjat, Providence Portland Medical Center
  • Rui Li, Providence Portland Medical Center
  • Pankaj Gore
  • Chris Fountain
  • Bill Hanson, University of California, Berkeley
  • Justin Skoble, University of California, Berkeley
  • Peter Lauer, University of California, Berkeley
  • Aimee L Murphy, University of California, Berkeley
  • Thomas Dubensky, University of California, Berkeley
  • Dirk G Brockstedt, University of California, Berkeley
  • Walter Urba
Link
Disciplines
Publication Date
January 1, 2015
DOI
10.1186/2051-1426-3-S2-P162
Citation Information
Marka Crittenden, Keith S Bahjat, Rui Li, Pankaj Gore, et al.. "Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas" Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 2 (2015) p. 162
Available at: http://works.bepress.com/walter-urba/125/